Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Venlafaxine Prolonged-release Capsules 150 mg at Steady State Under Fed Conditions in Healthy Thai Volunteers
TCTR20240427014Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of venlafaxine in major depressive disorder (MDD) (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20240427014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240427014.